TSS
CDLX icon

Two Sigma Securities’s Cardlytics CDLX Stock Holding History

Two Sigma Securities’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,440
Closed -$135K – 2645
2022
Q3 		$135K Buy
+1,440
New +$205K ﹤0.01% 2049

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.88B AUM 2.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $122M AUM 11.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.41B AUM 39.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Two Sigma Securities's CDLX Position: Q2 2026 in Review

Two Sigma Securities sold out of Cardlytics (CDLX) in Q2 2026, closing a stake of 3,162 shares — an estimated $33.2K sold.

Two Sigma Securities first reported a position in CDLX in Q4 2019 and held it in 4 quarters. The position peaked at $205K in Q4 2019. 42 funds tracked by Wall St. Rank hold CDLX as of Q2 2026.

  • Two Sigma Securities reported no remaining Cardlytics position as of Q2 2026 after selling out during the quarter.
  • Two Sigma Securities sold 3,162 Cardlytics shares in Q2 2026, an estimated $33.2K.
  • Two Sigma Securities first reported a position in Cardlytics in Q4 2019 and held it in 4 quarters.
  • Two Sigma Securities's Cardlytics position peaked at $205K in Q4 2019.
  • 42 funds tracked by Wall St. Rank held Cardlytics as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.